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Acob Harper
Predictive modeling, a technique to predict
and prevent wasteful or fraudulent spending
before it occurs, is the newest and potentially
most versatile fraud enforcement scheme ever
implemented by the United States Department of
Health and Human Services (HHS). Put into use
throughout 2011, predictive modeling is intended
to allow HHS to predict and confront potential
fraudsters before health care fraud occurs, thereby
limiting or eliminating the damages against the
United States and its health care program funds.
Banks and other financial institutions, as well as
advertising and marketing agencies, have been
using this technology for years with a great
degree of success. HHIIS anticipates that similar
results can be achieved in a health care context.
In limited instances, HHS and its contractors
have already employed predictive modeling
through data mining activities for review of
provider billings. If a contractor sees that a
provider presents questionable billing data, it will
commence an audit to further investigate whether
the billing and subsequent payment constitutes
fraud, waste, abuse, or some other overpayment.
This same activity, under predictive modeling,
will be conducted before payment is made to a
suspected provider. In abandoning the old "pay-
and-chase" model, HHS now hopes to lessen
the amount of outstanding overpayments due to
it, thereby better protecting the Medicare and
Medicaid Irust Funds and helping to reduce the
impending gap between costs and funding in
federal programs.
EMRs adHsia-hsca nerto
Acob Harper
The federal government relies primarily on two
powerful tools for health care fraud enforcement.
the Stark Law and the Anti-Kickback Statute
(AKS), codified at 42 U.S.C. 1395n and 42
U.S.C. §1320a-7b(b), irespectixvely. These laws,
in comhination with increased reimbursement
rates. incentivize health care providers and
hospitals to integrate their practices, hut also
create a complex regulatory scheme with which
health care prov iders often struggle to comply.
One method to facilitate the integration between
a hospital and its associated physicians is to
utilize the hospital's technological infrastructure,
including electronic medical record (EMR)
system and physical and technological security
measures demanded by HIPAA. Although
EMRs may raise other concerns in the eyes of
an investigator, meaningful use of such a system
will tend to prove that a hospital has sufficiently
integrated the practice of the employed physicians
and that such arrangement is legitimate and
reasonable. Moreover, EMR coordination can
increase the quality of patient care delivery;
coordinated efforts by the physician, hospital
staff, and other providers (such as diagnostic
and imaging facilities) will generally result in
better information, fewer mistakes, and improved
patient outcomes.
SusieAct PoidsTrnpaec to
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Section 6002 of the Patient Protection and
Affordable Care Act, known as the Physician
Payment Sunshine Act, increases transparency
regarding the financial relationships of physicians
and teaching hospitals with the manufacturers
of any device, pharmaceutical, biological, or
medical supply that are sold to public health
care programs, such as the Children's Health
Program, Medicare, or Medicaid. The act
requires manufacturers to file an annual report
that includes all payments or transfers of value
that exceed ten dollars made in the prior calendar
year. This encompasses, inter alia, consulting
fees, honoraria, gifts, entertainment, food, travel,
royalties, investment interests, and education.
The act also mandates the disclosure of any
financial oxwnership interest a physician or
their family memheirs have in manufacturing
companies oi giuup purchasing organizations,
therefore benefiting consumers hy illuminating
potential conflicts of interest. The secretary of
Health and Human Services wvill puhlish these
disclosures on a wvebsite, xvhich xwill enhance
government and public scrutiny of payments. Manufacturers will
need to be vigilant in avoiding violations under the Stark Lan,
federal and state anti-kickback laws, and the False Claims Act.
The Physician Payment Sunshine Act includes several exclusions
from the reporting requirement and explicitly preempts any state
statutes or regulation. Civil monetary penalties will be assessed for
violations. The penalties range from $1,000 to $10,000 for each
knowing failure to report, with an annual maximum fine of $1
million dollars. The first report under this act will be due on March
31, 2013.
The EARX Act argetsBreastCacri me
Jeff Whurzburg
According to the American Cancer Society, that ten thousand
women under the age of forty are diagnosed with breast cancer each
year. These women confront challenges in addition to the cancer
diagnosis, including possible negative impact upon reproductive
health. In 2009, Congresswoman Debbie Wasserman Schultz
(D-FL), a breast cancer survivor, sponsored the Young Women's
Breast Health and Awareness Requires Learning Young Act of
2009 (EARLY Act), (section 10413 of the Patient Protection and
Affordable Care Act). This act includes several ambitious targeted
objectives to increase awareness of breast cancer among young
women.
Section 399NN(a) of the EARLY Act requires the Centers for
Disease Control and Prevention (CDC) to create an evidence-based
education campaign to increase awareness of breast cancer among
women. The act specifies several subjects on which the campaign
should focus, including risk factors in women who are "at high
risk for breast cancer based on familial, racial, ethnic, and cultural
backgrounds."
As a result of the act, the CDC created the Advisory Committee on
Breast Cancer in Young Women. This committee is comprised of
fifteen members, consisting of medical professionals, researchers,
breast cancer survivors, and advocates. The committee already met
twice, in January and September of 2011.
Further, to increase knowledge and awareness, the act mandates
that the CDC issue grants to create a media campaign oriented to
young women and an education campaign directed to health care
professionals. In addition, the directors of the C DC and NIH are
required to conduct research regarding the prevention of breast
cancer in xvonmen. The EARLY Act prov ides an annual appiopriation
of $9 million bctxvecn 2010 and 2014.
Thomas Kirby
On October 20. 2011, the U.S. Department of Justice and the
Federal Trade Conmmission issued a joint policy statement, the
"Statement of Antitrust Enforcement Policy Regarding Accountable
Care Organizations Participating in the Medicare Shared Savings
Program." An accountable care organization is made of health care
providers who jointly offer services to decrease costs and enhance
the quality of patient care. The Patient Protection Affordable Care
Act encouraged such collaborations between health care providers
to innovate and improve care for U.S. consumers, but critics are
concerned about the potential for reduced competition resulting
from these collaborations, which may actually result in higher
prices or lower quality care.
Previously, health care providers faced uncertainty and lack of
guidance from antitrust regulators in connection with potential anti-
competitive consideration. On the one hand, antitrust law treats any
agreement among competitors to allocate markets or fix prices as
per se illegal, even if the agreement sets a maximum price. lowever,
U.S. antitrust regulators have explained thatjoint pricing agreements
among health care competitors will be analyzed under the more
lenient rule of reason. Under a rule of reason approach, any harm
to competition is considered alongside benefits to consumers, and a
significant benefit may outweigh a relatively insignificant harm. The
antitrust agencies also carved out an antitrust safety zone within
which collaborations between competitors are highly unlikely to
raise significant antitrust concerns.
This new policy statement clarifies the regulatory environment and
provides predictability for health care providers who participate in
the new system. U.S. antitrust regulators will continue to protect
competition in the markets served by accountable care organizations
by using market data compiled by the Centers for Medicare &
Medicaid Services while also vigilantly monitoring complaints.
Collaborations are covered by this policy irrespective of when they
were created, and newly formed accountable care organizations are
eligible for a voluntary expedited ninety-day review.
Achieng Rosa Ragwar
As a sign of the times., it is commonplace to see people walking
with, talking on, and playing with their smartphones. In an age
where electronics are taking our country by storm, we are becoming
more digitally interactive. This phenomenon is even going global, as
video chat and instant messaging have allowed us to conmunicate
with people all over the world. It is no surprise, then, that the digital
world is extending to the realm of health care and may soon be
central to the prov ision of health care services.
The iPhone has brought us rexvolutionary features such as
applications (apps) that enable easier, faster, and more interactive
usage. Apps are already being used to track nutrition and fitness
and to measure workout regimens. Xdditionally, "labs on a chip."
computer chips that instantly test for bacterial infections and the
safety of new drugs, haxve made their debut. iPhone apps that xwill
allow users to check in xxith their doctors remotely are cuirrently
under dcxvelopment.
Both health care providers and consumers share a mutual interest in
digitalized health care. Arecent study by the Consumer Electronics
Association revealed that consumers want to communicate with their
physicians through wireless devices. This would include sending
medical information to their doctor electronically, managing health
information online, and consulting with a physician through online
video.
Some are crediting President Obama's economic stimulus package
for initiating these changes in health care. According to these
proponents, the American Recovery and Reinvestment Act, which
President Obama signed into law in 2009, allocated $19 billion
to hospitals and physicians to use electronic medical records. The
projected move to new age electronics health care is expected to
save the country billions of dollars in health care costs over time.
Soon, we will see exactly where more advances in technology will
move health care innovation.
ACP ReleasesPoiinPpr"HatIfrmin
Tecnolgyand Privacy"
Julie Dabrowski
The American College of Physicians (ACP), a national organization
representing 132,000 internists, recently published a position
paper on the ethical use of patient information entitled, "Health
Information Technology & Privacy." The ACP paper expresses the
concerns of physicians over the reuse of personal and research data
and proposes a rule that would strengthen protections for research
subjects while allowing researchers to achieve scientific advances
without compromising their ethical obligations. ACP recommends
expanding regulations on institutional review board practices to
consider the preferences of research subjects whose tissue has been
stored. ACP recognizes that further study is required to resolve issues
of informed consent related to protected health information and
individually identifiable health information associated with existing
data and suggests that informed consent documents should clearly
disclose whether law enforcement agencies would have access to
patients' biobank data. The ACP paper states that various groups
including providers, governmental bodies, consumers, payers, and
researchers-should be brought together to draft appropriate data-
sharing practices and define consent requirements for research
activities. Challenges come with the health care industry's shift from
paper to electronic data records, and the ACP strongly suggests that
clinical enterprises and clinicians adopt policies and procedures that
allow health information to be shared safely and in accordance with
patients' preferences. Despite the challenges of moving to a digital
health care system, ACP expresses its conviction that widespread
adoption of health information technology will significantly
improve the quality of health care in America.
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